Correction to: Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma

Y Zhang; J Kim; A C Mueller; B Dey; Y Yang; D-H Lee; J Hachmann; S Finderle; D M Park; J Christensen; D Schiff; B Purow; A Dutta; R Abounader

doi:10.1038/s41418-018-0145-0

Correction to: Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma

Cell Death Differ. 2019 Jan;26(1):197. doi: 10.1038/s41418-018-0145-0.

Authors

Y Zhang¹, J Kim², A C Mueller^#³, B Dey^#³, Y Yang², D-H Lee⁴, J Hachmann², S Finderle², D M Park⁴, J Christensen⁵, D Schiff⁶, B Purow⁶, A Dutta³, R Abounader^{7

8}

Affiliations

¹ Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, USA. yz5h@virginia.edu.
² Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, USA.
³ Department of Biochemistry, University of Virginia, Charlottesville, VA, USA.
⁴ Department of Neurosurgery, University of Virginia, Charlottesville, VA, USA.
⁵ Pfizer Global Research and Development, La Jolla, CA, USA.
⁶ Department of Neurology, University of Virginia, Charlottesville, VA, USA.
⁷ Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, USA. ra6u@virginia.edu.
⁸ Cancer Center, University of Virginia, Charlottesville, VA, USA. ra6u@virginia.edu.

^# Contributed equally.

Abstract

Following publication of the article, the author named as "B Dey", wished to point out that his full name is "Bijan K. Dey". This was not reflected in the typesetting of the article, and as a consequence the article is not visible on Pub Med when a search is conducted on his full name.

Publication types

Published Erratum

Abstract

Publication types

Grants and funding